Growth Metrics

Vynleads (VYND) Asset Utilization Ratio (2021 - 2023)

Vynleads (VYND) reported Asset Utilization Ratio of 0.0 for Q1 2023, down 22.86% on a QoQ basis from 0.0 in Q4 2022.

Vynleads (VYND) has 3 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2023.

  • Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.0 (changed N/A YoY) and the FY2022 annual result came in at 0.0, down 87.09% from the prior year.
  • Asset Utilization Ratio fell to 0.0 in Q1 2023 per VYND's latest filing, from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.84 in Q1 2021 and bottomed at 0.0 in Q1 2023.
  • The 3-year median for Asset Utilization Ratio is 0.01 (2022), against an average of 0.17.
  • Peak annual rise in Asset Utilization Ratio reached 90.25% in 2022, while the deepest fall reached 97.89% in 2022.
  • Tracing VYND's Asset Utilization Ratio over 3 years: stood at 0.02 in 2021, then tumbled by 90.25% to 0.0 in 2022, then dropped by 22.86% to 0.0 in 2023.
  • Per Business Quant, the three latest VYND Asset Utilization Ratio figures stand at 0.0 (Q1 2023), 0.0 (Q4 2022), and 0.0 (Q3 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 0.37
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 2.16
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.40
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 0.88
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 0.57
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.20
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 0.62
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 1.61
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 0.62
10 Vynleads - - -2,028.00 -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.01
Dec 31, 2021 0.02
Sep 30, 2021 0.05
Jun 30, 2021 0.42
Mar 31, 2021 0.84